| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/14/2023 | PDS Biotechnology Corp | EDGE | Grant | Employee Stock Option (Right to Buy) | 9k | $5.13 | $46.2k | | 07/14/2023 |
| 06/07/2023 | Ambrx Biopharma Inc. | | Grant | Stock Option (right to buy) | 40k | $0.00 | $0 | | 05/18/2023 |
| 06/07/2023 | Ambrx Biopharma Inc. | | Grant | | 85k | $0.00 | $0 | | 05/18/2023 |
| 05/18/2023 | Ambrx Biopharma Inc. | | Grant | Stock Option (right to buy) | 17.5k | $0.00 | $0 | | 05/18/2023 |
| 05/18/2023 | Ambrx Biopharma Inc. | | Grant | Stock Option (right to buy) | 210k | $0.00 | $0 | | 05/18/2023 |
| 12/12/2022 | ZyVersa Therapeutics, Inc. | | Grant | Common Stock | 448.9k | $0.00 | $0 | | 12/12/2022 |
| 12/12/2022 | ZyVersa Therapeutics, Inc. | | Grant | Common Stock | 85.4k | $0.00 | $0 | See footnote | 12/12/2022 |
| 12/12/2022 | ZyVersa Therapeutics, Inc. | | Grant | Common Stock | 49.6k | $0.00 | $0 | See footnote | 12/12/2022 |
| 12/12/2022 | ZyVersa Therapeutics, Inc. | | Grant | Common Stock | 43.8k | $0.00 | $0 | See footnote | 12/12/2022 |
| 12/12/2022 | ZyVersa Therapeutics, Inc. | | Grant | Series A Convertible Preferred Stock | 18 | $10.00 | $180 | | 12/12/2022 |
| 12/12/2022 | ZyVersa Therapeutics, Inc. | | Grant | Stock Options (right to buy) | 139k | $5.03 | $699.1k | | 12/12/2022 |
| 12/12/2022 | ZyVersa Therapeutics, Inc. | | Grant | Stock Options (right to buy) | 168.8k | $5.03 | $848.9k | | 12/12/2022 |
| 12/12/2022 | ZyVersa Therapeutics, Inc. | | Grant | Stock Options (right to buy) | 264.8k | $11.58 | $3.1M | | 12/12/2022 |
| 12/12/2022 | ZyVersa Therapeutics, Inc. | | Grant | Stock Options (right to buy) | 126.1k | $16.36 | $2.1M | | 12/12/2022 |
| 12/12/2022 | ZyVersa Therapeutics, Inc. | | Grant | Stock Options (right to buy) | 79.4k | $16.36 | $1.3M | | 12/12/2022 |
| 12/12/2022 | ZyVersa Therapeutics, Inc. | | Grant | Warrant (right to buy) | 70.9k | $6.90 | $489.1k | | 12/12/2022 |
| 12/12/2022 | ZyVersa Therapeutics, Inc. | | Grant | Warrant (right to buy) | 3k | $11.58 | $35k | | 12/12/2022 |
| 12/12/2022 | ZyVersa Therapeutics, Inc. | | Grant | Warrant (right to buy) | 17.9k | $11.58 | $207.3k | See footnote | 12/12/2022 |
| 12/12/2022 | ZyVersa Therapeutics, Inc. | | Grant | Warrant (right to buy) | 1.8k | $11.50 | $20.1k | | 12/12/2022 |
| 06/28/2022 | PDS Biotechnology Corp | EDGE | Grant | Stock Option (Right to Buy) | 9k | $3.90 | $35.1k | | 06/28/2022 |
| 06/17/2021 | PDS Biotechnology Corp | EDGE | Grant | Stock Option (Right to Buy) | 9k | $9.95 | $89.6k | | 06/15/2021 |
| 06/15/2021 | PDS Biotechnology Corp | EDGE | Purchase | Common Stock | 5.9k | $8.50 | $50k | | 06/15/2021 |
| 06/23/2020 | PDS Biotechnology Corp | EDGE | Grant | Stock Option (Right to Buy) | 9k | $1.45 | $13k | | 06/23/2020 |
| 02/14/2020 | PDS Biotechnology Corp | EDGE | Grant | Common Stock | 38.4k | $1.30 | $49.9k | | 02/14/2020 |
| 06/28/2019 | PDS Biotechnology Corp | EDGE | Grant | Stock Option (Right to Buy) | 9k | $5.99 | $53.9k | | 06/28/2019 |